A phase II trial of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer

2019 ◽  
Vol 154 ◽  
pp. 23 ◽  
Author(s):  
E. Zsiros ◽  
P.J. Frederick ◽  
S.N. Akers ◽  
K. Attwood ◽  
K. Wang ◽  
...  
Keyword(s):  
Fallopian Tube ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer ◽  
Metronomic Cyclophosphamide

Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, fallopian tube, and primary peritoneal cancer

2014 ◽  
Vol 133 ◽  
pp. 41
Author(s):  
A. Van Arsdale ◽  
M.H. Einstein ◽  
M.A. Brewer ◽  
P.F. Timmins ◽  
J.D. Wright ◽  
...  
Keyword(s):  
Fallopian Tube ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer ◽  
Platinum Sensitive
Sign in / Sign up

Export Citation Format

Share Document